Day: July 1, 2023

CALGARY, Alberta, July 01, 2023 (GLOBE NEWSWIRE) — Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to announce the signing of a $9.0 million seismic data licensing sales contract. Revenue of $5.4 million related to the initial delivery of data has been recognized upon the execution of the contract, with the majority of the remaining data to be delivered in 2023, and the final tranche of data to be delivered in 2024. The remaining revenue after the initial delivery of data will be recognized when the data is delivered to the customer. The sale announced today, with the initial data delivery complete, brings June 30, 2023 year-to-date seismic data library sales revenue to $17.1 million, an 84% increase over 2022 annual data sales revenue. These second quarter figures are preliminary and have not been...

NIO delivered 10,707 vehicles in June 2023 NIO delivered 23,520 vehicles in the three months ended June 2023 NIO started ramping up deliveries of ET5 Touring and All-New ES8 in June 2023 Cumulative deliveries of NIO vehicles reached 344,117 as of June 30, 2023SHANGHAI, China, July 01, 2023 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced its June and second quarter 2023 delivery results. NIO delivered 10,707 vehicles in June 2023. The deliveries consisted of 6,383 premium smart electric SUVs, and 4,324 premium smart electric sedans. NIO delivered 23,520 vehicles in the second quarter of 2023. Cumulative deliveries of NIO vehicles reached 344,117 as of June 30, 2023. On June 15, 2023, NIO launched...

Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) biosimilar offers US patients reduced injection volume in citrate-free formulationAs one of the only adalimumab HCF biosimilars approved in the US, Hyrimoz HCF expands access for millions of people with serious inflammatory diseasesLaunch builds upon Sandoz global biosimilars legacy, with Hyrimoz 50 mg/mL having nearly 120 million days of patient experience across 41 countries1Basel, July 1, 2023 – Sandoz, a global leader in generic pharmaceuticals and biosimilars, today announced that the citrate-free high-concentration formulation (HCF) of its biosimilar Hyrimoz® (adalimumab-adaz) injection will be available in the United States starting July 1. Hyrimoz HCF (100 mg/mL) is approved to treat all indications no longer covered by the regulatory exclusivity for the reference...

1 July 2023 Reference is made to the stock exchange announcement published on 27 June 2023 by Interoil Exploration and Production ASA the (“Company“) regarding the successful completion of an acquisition of additional participation in Santa Cruz concessions. As part of the closing of the transaction, the Company’s board of directors resolved to issue 4,824,591 shares to Echo at a subscription price of NOK 1.15 per share as payment in kind of GBP 400,000 of the purchase price of part of the acquisition. The new share capital pertaining to this has now been registered with the Norwegian Register of Business Enterprises, and as such, the new share capital of the Company is NOK 100,672,137, divided into 201,344,274 shares, each with a par value of NOK 0.50. Please direct any further questions to: ir@interoil.no The disclosure...

WHITE SULPHUR SPRINGS, Mont., June 30, 2023 (GLOBE NEWSWIRE) — Sandfire Resources America Inc. (“Sandfire America” or the “Company”) announces that it has entered into a second variation agreement (the “Second Variation“) to its bridge loan agreement, as amended (the “Bridge Loan”) with Sandfire BC Holdings (Australia) Pty Ltd. (“Sandfire BC“), the Company’s largest shareholder, and Tintina Montana Inc., a wholly-owned subsidiary of the Company (“Tintina Montana“). Pursuant to the Second Variation, the amount available to be borrowed under the Second Variation, Variation and Bridge Loan will be increased from an aggregate of up to US$22.0 million to an aggregate of up to US$32.0 million through one or more advances, and the latest maturity will be extended from June...

BEIJING, China, July 01, 2023 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company delivered 32,575 vehicles in June 2023, surpassing the 30,000 monthly delivery mark for the first time and representing an increase of 150.1% year over year. This brought the Company’s second quarter deliveries to 86,533, up 201.6% year over year. The Company has already surpassed its total vehicle deliveries for the entire year of 2022 with its deliveries in the first half of 2023. “Benefiting from the comprehensive enhancement of our organizational processes and operating capabilities, our monthly deliveries exceeded 30,000 for the first time, making Li Auto currently the only Chinese premium brand to achieve this milestone. For the...

EDMONTON, Alberta, June 30, 2023 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV:BTCW; OTCQB:BCNWF), announces a shares for debt arrangement. Shares for Debt The Company plans to issue 1,152,273 Common Shares having an aggregate value of $63,375 related to the balance of the earn-out on the Equibytes acquisition, previously announced on September 8, 2021. The Common Shares will be issued at a deemed price of $0.055 per Common Share, being equal to the closing trading price of the Common Shares on the TSXV on the date of this news release. The issuance of the Common Shares is subject to the approval of the TSXV, and such Common Shares will be subject to a four-month plus one day hold period pursuant to TSXV policies. About Bitcoin Well Bitcoin Well is in the business of future-proofing money. We do...

Singular Narrative Management to provide strategic business consulting, product development, and brand marketing services to Lifeist and its operating divisions TORONTO, June 30, 2023 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, is pleased to announce that it has entered into a Consulting Agreement (the “Agreement”) with Singular Narrative Management Ltd. (“Singular”), an arm’s length party, for the provision of strategic business consulting, product development, and brand marketing services to the Company as well as other services that do not include investor relations or promotional activities...